BYSI - BeyondSpring Inc. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.78 0.15 (8.43%) --- --- 0.0 (0.0%) --- 0.15 (8.43%) 0.0 (0.0%) 0.0 (0.0%)

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
0.11
Diluted EPS:
Basic P/E:
17.5455
Diluted P/E:
RSI(14) 1m:
100.0
VWAP:
1.93
RVol:

Events

Period Kind Movement Occurred At

Related News